Metrics as of 10/17/2026, 07:38 AM (Berlin time), refresh in progress.
IQVIA Holdings Stock
IQVIA Holdings Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Ari Bousbib
- Employees
- 94,000
- Market cap
- $43.9 B
- IPO
- 09/05/2013
IQVIA Holdings Inc. (IQV) operates in the Healthcare / Medical - Diagnostics & Research sector as a global provider of analytical insights and clinical research services. The US-based company, headquartered in Durham, North Carolina, is divided into segments including Technology & Analytics Solutions, Research &…
AI-generated company profile based on the figures on this page, last updated on 01/10/2026. Not investment advice.
IQVIA Holdings stock: price history
1D
-1.5%
1W
+2.7%
1M
-0.7%
6M
+51.3%
YTD
+18.4%
1Y
+29.7%
2Y
+14.5%
5Y
+7.3%
10Y
+254.3%
Next earnings date
Next earnings date
27/10/2026 (in 10 days)
Volatility around earnings
~90% stronger price swings than usual
IQVIA Holdings stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
3 more assignments (Enabler/Second row) Pro-only.
IQVIA Holdings Inc. operates as a global service provider for the life sciences industry, offering a comprehensive range of analytics, technology solutions, and clinical research services. The business model is organized into three core segments: technology and analytics solutions, research and development services, and commercial and medical solutions. A key focus lies on cloud-native applications, the delivery of real-world data for healthcare decision-making, and extensive laboratory services in genomics and bioanalytics. The company supports pharmaceutical, biotech, and medical device companies in conducting clinical trials and optimizing commercial processes.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Wide
- Moat type
- Switching costs
- Capital intensity
- Medium
- Customer concentration
- Unknown
Suppliers & customers in our universe
argenx SEDescriptionAsk the agents about IQVIA Holdings
Analyst assessment of IQVIA Holdings
PRICE TARGET LOW
US$240.00
CONSENSUS
US$284.64
MEDIAN
US$287.00
PRICE TARGET HIGH
US$345.00
1
STRONG BUY
36
BUY
7
HOLD
1
SELL
0
STRONG SELL
45
TOTAL · Buy
As of: 14/10/2026
IQVIA Holdings stock metrics
P/E
32.83
P/B
7.23
EV/EBITDA
16.51
RETURN ON EQUITY
4.1%
NET MARGIN
5.9%
DEBT/EQUITY
2.63
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
94.9%
FLOAT SHARES
156,249,842
AVG. DAILY VOLUME (30D)
1,483,200
Insider transactions (SEC)
Berkshire James G.
Berkshire James G.
Berkshire James G.
STAUB W RICHARD
Patel Bhavik
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.5%
Search (Google Trends)
Forums (Reddit)
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about IQVIA Holdings stock
What does IQVIA Holdings do?
IQVIA Holdings Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Ari Bousbib, the company employs around 94,000 people.
The IPO was on 09/05/2013; the stock trades on NYSE under the ticker IQV.
What do analysts say about IQVIA Holdings stock?
45 analysts rate the stock, the consensus is Buy (as of 14/10/2026).
The average price target is US$284.64, ranging from US$240.00 to US$345.00, with a median of US$287.00.
This is an external assessment, not a statement by Market Jury.
When does IQVIA Holdings report next?
The next earnings date is 27/10/2026.
Around past earnings, price swings were roughly 90% stronger than usual.
Does IQVIA Holdings pay a dividend?
No, IQVIA Holdings currently does not pay a dividend.
Which stocks are comparable to IQVIA Holdings?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, Waters, Illumina, IDEXX Laboratories and Mettler-Toledo International.
How can I get IQVIA Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess IQVIA Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.